Review



cfse stock solution  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    MedChemExpress cfse stock solution
    Cfse Stock Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 186 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA-SE/pm42869131-83-4-7
    Average 97 stars, based on 186 article reviews
    cfse stock solution - by Bioz Stars, 2026-11
    97/100 stars

    Images

    Related Articles

    Suspension:

    Article Title: KYNU in Gastric Cancer Cells Promotes Tumor Progression by Influencing Macrophage Polarization Via PF4.
    Article Snippet: .. The cell suspension was then incubated with CFSE (MedChemExpress, China) under light- protected conditions at 37°C for 10 min. ..

    Incubation:

    Article Title: KYNU in Gastric Cancer Cells Promotes Tumor Progression by Influencing Macrophage Polarization Via PF4.
    Article Snippet: .. The cell suspension was then incubated with CFSE (MedChemExpress, China) under light- protected conditions at 37°C for 10 min. ..

    TUNEL Assay:

    Article Title: An Engineered Nano‐Bridging Strategy Remodels the Immune Microenvironment of Esophageal Squamous Cell Carcinoma via STING Pathway Activation
    Article Snippet: .. The following materials were procured for this study: diABZI STING agonist‐1, DSPE–PEG 2000, DSPE–PEG–azide, macrophage colony‐stimulating factor (M‐CSF), IL‐4, IL‐13, PKH 26, and CFSE from MedChemExpress; branched PEI (Mw ∼ 25,000) and 4,6‐diamidino‐2‐phenylindole (DAPI) from Sigma–Aldrich; DMEM medium and FBS from Gibco; an anti‐Ki67 antibody from Abcam; and a one‐step TUNEL in situ apoptosis kit from Elabscience. .. Additionally, commercial reagent kits for the determination of alanine transaminase, aspartate transaminase, alkaline phosphatase, creatinine, and blood urea nitrogen were supplied by Nanjing JianCheng Bioengineering Institute (Nanjing, China).

    In Situ:

    Article Title: An Engineered Nano‐Bridging Strategy Remodels the Immune Microenvironment of Esophageal Squamous Cell Carcinoma via STING Pathway Activation
    Article Snippet: .. The following materials were procured for this study: diABZI STING agonist‐1, DSPE–PEG 2000, DSPE–PEG–azide, macrophage colony‐stimulating factor (M‐CSF), IL‐4, IL‐13, PKH 26, and CFSE from MedChemExpress; branched PEI (Mw ∼ 25,000) and 4,6‐diamidino‐2‐phenylindole (DAPI) from Sigma–Aldrich; DMEM medium and FBS from Gibco; an anti‐Ki67 antibody from Abcam; and a one‐step TUNEL in situ apoptosis kit from Elabscience. .. Additionally, commercial reagent kits for the determination of alanine transaminase, aspartate transaminase, alkaline phosphatase, creatinine, and blood urea nitrogen were supplied by Nanjing JianCheng Bioengineering Institute (Nanjing, China).

    Labeling:

    Article Title: Triple targeting of STING, TGF-β, and PD-L1 boosts CXCL16–CXCR6 signaling for potent antitumor response
    Article Snippet: To assess in vitro cytotoxicity, 1 × 10 5 OT-1 CD8 + T cells were co-cultured with 1 × 10 4 murine lymphoma cells stably expressing the OVA antigen (E.G7-OVA, CTCC-001-0136, MeisenCTCC) in 96-well plates. .. Before co-culture, E.G7-OVA cells were labeled with CFSE (5 μM, 150347-59-4, MCE). ..

    Article Title: Exosomal NEAT1 from tumor stem cells induces SIRPA + macrophages to enhance immune evasion and glioblastoma progression via upregulating the HSP90B1/STAT3 axis.
    Article Snippet: .. Then cells were labeled with 1 μL CFSE (MCE, USA) at 37 °C for 30 minutes in the AR TIC LE IN PR ES S dark. ..

    Article Title: Exosomal NEAT1 from tumor stem cells induces SIRPA + macrophages to enhance immune evasion and glioblastoma progression via upregulating the HSP90B1/STAT3 axis.
    Article Snippet: .. Tumor cells were then labeled with 1 μL CFSE (MCE, USA) at 37°C for 30 minutes in the dark. ..

    Article Title: Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8 + T cell activation
    Article Snippet: .. For the in vitro T cell proliferation assay, CD8 + T cells were labeled with 2.5 μM CFSE (MedChemExpress, HY-D0938) at 37°C for 10 minutes. .. For CellTrace Violet staining (Thermo Fisher Scientific, C34557 ), refer to the manufacturer’s instructions.

    In Vitro:

    Article Title: Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8 + T cell activation
    Article Snippet: .. For the in vitro T cell proliferation assay, CD8 + T cells were labeled with 2.5 μM CFSE (MedChemExpress, HY-D0938) at 37°C for 10 minutes. .. For CellTrace Violet staining (Thermo Fisher Scientific, C34557 ), refer to the manufacturer’s instructions.

    Proliferation Assay:

    Article Title: Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8 + T cell activation
    Article Snippet: .. For the in vitro T cell proliferation assay, CD8 + T cells were labeled with 2.5 μM CFSE (MedChemExpress, HY-D0938) at 37°C for 10 minutes. .. For CellTrace Violet staining (Thermo Fisher Scientific, C34557 ), refer to the manufacturer’s instructions.



    Similar Products

    93
    Dojindo Labs nih3t3 cells
    Nih3t3 Cells, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/Cellstain+CFSE/pm42868717-86-5-12
    Average 93 stars, based on 1 article reviews
    nih3t3 cells - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    95
    TargetMol carboxyfluorescein diacetate succinimidyl ester 122 cfse
    Carboxyfluorescein Diacetate Succinimidyl Ester 122 Cfse, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFSE/pm42988020-57-0-8
    Average 95 stars, based on 1 article reviews
    carboxyfluorescein diacetate succinimidyl ester 122 cfse - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    Beyotime cfda se dye
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfda Se Dye, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA+SE/pmc13755073-158-19-23
    Average 96 stars, based on 1 article reviews
    cfda se dye - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Beyotime cfdase
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfdase, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA+SE/pm42995598-54-0-6
    Average 96 stars, based on 1 article reviews
    cfdase - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Beyotime cfda se cfse
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfda Se Cfse, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA+SE/pm42886791-415-9-13
    Average 96 stars, based on 1 article reviews
    cfda se cfse - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    MedChemExpress cfse stock solution
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfse Stock Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA-SE/pm42869131-83-4-7
    Average 97 stars, based on 1 article reviews
    cfse stock solution - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress cfse
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Cfse, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA-SE/10__1002_slash_adfm__78518-285-0-6
    Average 97 stars, based on 1 article reviews
    cfse - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Beyotime wild type wt t gondii tachyzoites
    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with <t>CFDA</t> <t>SE,</t> and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.
    Wild Type Wt T Gondii Tachyzoites, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cfse/CFDA+SE/pmc13689411-165-10-23
    Average 96 stars, based on 1 article reviews
    wild type wt t gondii tachyzoites - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with CFDA SE, and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.

    Journal: Alzheimer's & Dementia

    Article Title: Targeting peripheral cathepsin E restricts CD8 + T‐cell neuroinvasion and ameliorates Alzheimer's disease pathology

    doi: 10.1002/alz.71994

    Figure Lengend Snippet: CatE deficiency impairs T‐cell migration in AD mice and patients. (A) Schematic of the experimental procedure: An inverted 8 µm pore‐size insert was seeded with b.End3 cells until > 90% confluence, then placed upright in a 24‐well plate. MG6 cells were added to the upper surface and treated with Aβ or left untreated for 24 hours. Splenic T cells from AD or CatE‐KO AD mice were activated, labeled with CFDA SE, and added to the wells. After 12 hours, migrated T cells were quantified, and the insert membrane was removed and stained for CD31 and Hoechst. (B) Representative images showing cells infiltrating the endothelial layer. Blue: Hoechst 33258; red: CD31; green: CFDA SE‐labeled T cells. (C) Quantification of the number of CFDA SE + T cells that migrated through the b.End3 endothelial monolayer per field of view, corresponding to (B); n = 5 per group. (D) Illustration of the microfluidic device used for T‐cell migration experiments. Because Unit 4 is oppositely oriented within the imaging field, its apparent migration direction is reversed relative to Units 1–3; in all conditions, however, T cells migrate from the cell‐loading side toward the chemoattractant‐containing side. (E) Representative images of CD8+ T cells treated with either 2.5 nM or 5 nM CatE inhibitor, or untreated, captured at the start (0 minutes) and end (30 minutes) of the experiment. Control channels contained RPMI 1640 medium alone. Scale bars = 100 µm. (F) Representative traces in panel (E). (G) Quantification of the number of CD8 + T cells from healthy controls and patients with AD migrating beyond one‐third of the migration channel length under the indicated conditions. Healthy controls, n = 4 per group; patients with AD, n = 5 per group. Data represent the mean ± SEM. Statistical significance was analyzed by one‐way ANOVA followed by Bonferroni's post hoc test. ** p < 0.01, *** p < 0.001. Aβ, β amyloid; AD, Alzheimer's disease; ANOVA, analysis of variance; KO, knockout.

    Article Snippet: T cells were isolated from the spleens of AD or CatE‐KO AD mice, activated in culture, and stained with CFDA SE dye (C1031, Beyotime) before being added to the 24‐well plate.

    Techniques: Migration, Pore Size, Labeling, Membrane, Staining, Imaging, Control, Analysis, Knock-Out